Teva (Seite 64)
eröffnet am 30.01.05 10:31:56 von
neuester Beitrag 28.04.24 12:01:03 von
neuester Beitrag 28.04.24 12:01:03 von
Beiträge: 5.546
ID: 948.841
ID: 948.841
Aufrufe heute: 2
Gesamt: 705.713
Gesamt: 705.713
Aktive User: 0
ISIN: US8816242098 · WKN: 883035 · Symbol: TEVA
13,980
USD
-0,50 %
-0,070 USD
Letzter Kurs 02:04:00 NYSE
Neuigkeiten
30.04.24 · Business Wire (engl.)  |
16.04.24 · Business Wire (engl.) |
16.04.24 · Business Wire (engl.) |
11.04.24 · Business Wire (engl.) |
Werte aus der Branche Pharmaindustrie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,2000 | +471,16 | |
| 13,110 | +38,44 | |
| 1,1514 | +30,84 | |
| 0,9150 | +21,84 | |
| 1,2100 | +21,00 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 5,0300 | -19,90 | |
| 36,70 | -22,87 | |
| 2,5500 | -25,22 | |
| 1,3500 | -26,63 | |
| 2,7280 | -29,14 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 66.928.421 von cure am 10.02.21 14:09:53
OHA!
https://seekingalpha.com/news/3660540-teva-gains-company-say…
irgendwas passiert ......
Die nächsten 10% werden sehr schwierig. Sind nun an einem sehr starken Widerstandsbereich angekommen (13 - 13,50$). Eigentlich ein guter Zeitpunkt für Gewinnmitnahmen, aber fundamental betrachtet schade sich zu diesem Preis von Anteilen zu trennen.
Antwort auf Beitrag Nr.: 66.736.711 von cure am 01.02.21 08:39:08
...und der Kurs liest wohl mit ..
Zitat von cure: 👍, dem ist nichts hinzuzufügen 👍
...und der Kurs liest wohl mit ..
Dan Polsters Zeitplan für die Opioid-Klage steht. Prozeßbeginn wäre dann am 4.Okt.2021.
Ein möglicher Vergleich könnte dann in der Zeit zwischen dem Ende der Sommerferien und dem dem eigentlichen Prozeßbeginn liegen.
https://www.ohnd.uscourts.gov/sites/ohnd/files/3595.pdf
Case: 1:17-md-02804 Doc #: 3595 Filed: 01/06/21 2 of 5. PageID #: 507695
E. CT3 Fact Discovery Deadlines
7. February 26, 2021 - Deadline to serve third party subpoenas.
8. March 5, 2021 - Close of party fact discovery.
9. March 19, 2021 - Close of third-party discovery.
[Section F is unchanged from Dkt. # 3329.]
G. Expert Discovery Deadlines
1. April 16, 2021 – Plaintiffs shall serve expert reports and, for each expert,
provide two proposed deposition dates between May 3, 2021 and May 21,
2021.
2. May 28, 2021 – Defendants shall serve expert reports and, for each expert,
provide two proposed deposition dates between June 14, 2021 and June
29, 2021.
H. Daubert and Dispositive Motions
1. July 5, 2021 – Deadline for Daubert and dispositive motions.2
2. July 30, 2021 – Deadline for responses to Daubert and dispositive
motions.
3. August 9, 2021 – Deadline for replies in support of Daubert and
dispositive motions.
I. Motions in limine
1. August 9, 2021 – Motions in limine due.
2. August 30, 2021 – Responses to motions in limine due.
3. September 7, 2021 – Replies to motions in limine due.
[Section J is unchanged from Dkt. # 3329.]
2 The Parties have agreed that these motions will be due by July 5, 2021, regardless of the
federal holiday.
Case: 1:17-md-02804 Doc #: 3595 Filed: 01/06/21 2 of 5. PageID #: 507695
3
K. Pre-Trial Deadlines
1. July 1, 2021 - Parties to exchange additional proposed jury instructions,
verdict forms, and interrogatories.3
2. July 8, 2021 - Parties to email jury questionnaire to the Special Master.
3. [Deadline for exchange of affirmative deposition designations is included
in the parties’ stipulation.]
4. Preliminary statements.
(a) July 8, 2021 – Parties to exchange proposed joint preliminary
statements.
(b) July 15 , 2021 - Parties to email joint preliminary statement to
Chambers.
5. July 15, 2021 - Parties to file jury instructions, verdict forms, and
interrogatories, including objections where agreement is lacking.
6. July 15, 2021 - Parties to email exhibit-list form to Chambers.
7. Exchange of witness and exhibit lists
(a) June 15, 2021 - Parties to exchange witness lists.
(b) [Deadline for exchange of exhibit lists is included in the parties’
stipulation.]
(c) June 24, 2021 – Plaintiffs as a group will jointly identify no more
than 50 fact witnesses whom they are most likely to call at trial.
(d) July 1, 2021 – Defendants as a group will jointly identify no more
than 50 fact witnesses whom they are most likely to call at trial.
8. Filing of witness lists and exhibit lists
(a) July 26, 2021 - Parties to file witness lists.
(b) September 10, 2021 – Parties to file exhibit lists.
3 The Court has already received copious submissions on these topics from the parties in this and other
Case Tracks. The parties are directed not to submit materials that are repetitive or that contravene the Court’s earlier
conclusions on jury instructions.
Case: 1:17-md-02804 Doc #: 3595 Filed: 01/06/21 3 of 5. PageID #: 507696
4
9. [Deadline to exchange responsive deposition designations, objections to
affirmative designations, and non-repetitive and non-responsive
designations from depositions previously affirmatively designated during
this period is included in the parties’ stipulation.]
10. August 9, 2021 - Parties to file proposed questions for the Court’s voir dire.
11. August 12, 2021 - Deadline to depose “most likely” witnesses who were
not earlier deposed. A party must make a showing of good cause why they
did not take the deposition of such a witness during the regular discovery
period. Such depositions may also be taken by agreement. A party must
show good cause to call at trial a witness who was not among the
identified “most likely” trial witnesses.
12. August 19, 2021 - Trial briefs due.
13. [Deadline for exchange of final deposition designations and objections is
included in the parties’ stipulation.]
14. August 23, 2021 – Deadline to file objections to witnesses.
(a) [Deadline to file objections to exhibits is included in the parties’
stipulation.]
15. [Deadline to file objections to deposition designations is included in the
parties’ stipulation.]
(a) [Deadline to submit advance exhibit objections is included in the
parties’ stipulation.]
16. September 17, 2021 - Completed jury questionnaires to be distributed to
trial counsel.
17. September 21, 2021 - Court and trial counsel to review jury
questionnaires.
18. September 28, 2021 - Final pretrial conference.
Case: 1:17-md-02804 Doc #: 3595 Filed: 01/06/21 4 of 5. PageID #: 507697
5
L. Trial
1. September 29, 2021 - Jury selection begins.
2. October 4, 2021 - Opening statements.
IT IS SO ORDERED.
/s/ Dan Aaron Polster
DAN AARON POLSTER
UNITED STATES DISTRICT JUDGE
Ein möglicher Vergleich könnte dann in der Zeit zwischen dem Ende der Sommerferien und dem dem eigentlichen Prozeßbeginn liegen.
https://www.ohnd.uscourts.gov/sites/ohnd/files/3595.pdf
Case: 1:17-md-02804 Doc #: 3595 Filed: 01/06/21 2 of 5. PageID #: 507695
E. CT3 Fact Discovery Deadlines
7. February 26, 2021 - Deadline to serve third party subpoenas.
8. March 5, 2021 - Close of party fact discovery.
9. March 19, 2021 - Close of third-party discovery.
[Section F is unchanged from Dkt. # 3329.]
G. Expert Discovery Deadlines
1. April 16, 2021 – Plaintiffs shall serve expert reports and, for each expert,
provide two proposed deposition dates between May 3, 2021 and May 21,
2021.
2. May 28, 2021 – Defendants shall serve expert reports and, for each expert,
provide two proposed deposition dates between June 14, 2021 and June
29, 2021.
H. Daubert and Dispositive Motions
1. July 5, 2021 – Deadline for Daubert and dispositive motions.2
2. July 30, 2021 – Deadline for responses to Daubert and dispositive
motions.
3. August 9, 2021 – Deadline for replies in support of Daubert and
dispositive motions.
I. Motions in limine
1. August 9, 2021 – Motions in limine due.
2. August 30, 2021 – Responses to motions in limine due.
3. September 7, 2021 – Replies to motions in limine due.
[Section J is unchanged from Dkt. # 3329.]
2 The Parties have agreed that these motions will be due by July 5, 2021, regardless of the
federal holiday.
Case: 1:17-md-02804 Doc #: 3595 Filed: 01/06/21 2 of 5. PageID #: 507695
3
K. Pre-Trial Deadlines
1. July 1, 2021 - Parties to exchange additional proposed jury instructions,
verdict forms, and interrogatories.3
2. July 8, 2021 - Parties to email jury questionnaire to the Special Master.
3. [Deadline for exchange of affirmative deposition designations is included
in the parties’ stipulation.]
4. Preliminary statements.
(a) July 8, 2021 – Parties to exchange proposed joint preliminary
statements.
(b) July 15 , 2021 - Parties to email joint preliminary statement to
Chambers.
5. July 15, 2021 - Parties to file jury instructions, verdict forms, and
interrogatories, including objections where agreement is lacking.
6. July 15, 2021 - Parties to email exhibit-list form to Chambers.
7. Exchange of witness and exhibit lists
(a) June 15, 2021 - Parties to exchange witness lists.
(b) [Deadline for exchange of exhibit lists is included in the parties’
stipulation.]
(c) June 24, 2021 – Plaintiffs as a group will jointly identify no more
than 50 fact witnesses whom they are most likely to call at trial.
(d) July 1, 2021 – Defendants as a group will jointly identify no more
than 50 fact witnesses whom they are most likely to call at trial.
8. Filing of witness lists and exhibit lists
(a) July 26, 2021 - Parties to file witness lists.
(b) September 10, 2021 – Parties to file exhibit lists.
3 The Court has already received copious submissions on these topics from the parties in this and other
Case Tracks. The parties are directed not to submit materials that are repetitive or that contravene the Court’s earlier
conclusions on jury instructions.
Case: 1:17-md-02804 Doc #: 3595 Filed: 01/06/21 3 of 5. PageID #: 507696
4
9. [Deadline to exchange responsive deposition designations, objections to
affirmative designations, and non-repetitive and non-responsive
designations from depositions previously affirmatively designated during
this period is included in the parties’ stipulation.]
10. August 9, 2021 - Parties to file proposed questions for the Court’s voir dire.
11. August 12, 2021 - Deadline to depose “most likely” witnesses who were
not earlier deposed. A party must make a showing of good cause why they
did not take the deposition of such a witness during the regular discovery
period. Such depositions may also be taken by agreement. A party must
show good cause to call at trial a witness who was not among the
identified “most likely” trial witnesses.
12. August 19, 2021 - Trial briefs due.
13. [Deadline for exchange of final deposition designations and objections is
included in the parties’ stipulation.]
14. August 23, 2021 – Deadline to file objections to witnesses.
(a) [Deadline to file objections to exhibits is included in the parties’
stipulation.]
15. [Deadline to file objections to deposition designations is included in the
parties’ stipulation.]
(a) [Deadline to submit advance exhibit objections is included in the
parties’ stipulation.]
16. September 17, 2021 - Completed jury questionnaires to be distributed to
trial counsel.
17. September 21, 2021 - Court and trial counsel to review jury
questionnaires.
18. September 28, 2021 - Final pretrial conference.
Case: 1:17-md-02804 Doc #: 3595 Filed: 01/06/21 4 of 5. PageID #: 507697
5
L. Trial
1. September 29, 2021 - Jury selection begins.
2. October 4, 2021 - Opening statements.
IT IS SO ORDERED.
/s/ Dan Aaron Polster
DAN AARON POLSTER
UNITED STATES DISTRICT JUDGE
Trading Spotlight
Antwort auf Beitrag Nr.: 66.725.455 von codiman am 31.01.21 12:18:46👍, dem ist nichts hinzuzufügen 👍
Antwort auf Beitrag Nr.: 66.507.965 von jossiff am 19.01.21 16:48:45Es steht und fällt mit der rechtlichen Situation.
Der Kare hat sehr gute Arbeit gemacht.
Die Fehler sind allen von seinen Vorgängern gemacht worden.
Aber die Drohungen des Doj liegen schwer auf dem Kurs, so dass er weiter am Boden liegt.
Sollte man sich aber hier einigen, und es wird nicht so stark aufgesattelt, dann ist Teva ruckzuck bei Kursen über 20.
Warum?
Dann sieht der Markt ein gesundes Kerngeschäft und ein sehr effizientes Generikaunternehmen und
die Biosemiliar Phantasie + Wachstum.
VG codiman
Der Kare hat sehr gute Arbeit gemacht.
Die Fehler sind allen von seinen Vorgängern gemacht worden.
Aber die Drohungen des Doj liegen schwer auf dem Kurs, so dass er weiter am Boden liegt.
Sollte man sich aber hier einigen, und es wird nicht so stark aufgesattelt, dann ist Teva ruckzuck bei Kursen über 20.
Warum?
Dann sieht der Markt ein gesundes Kerngeschäft und ein sehr effizientes Generikaunternehmen und
die Biosemiliar Phantasie + Wachstum.
VG codiman
Antwort auf Beitrag Nr.: 66.508.907 von jossiff am 19.01.21 17:36:05meine erste posi war bei 12€ hab dann stetig nach unten zugekauft um zu verbilligen...
aktuell ist meine posi von 1500 ist groß genug... muss schon echt nochmal fett runter gehen um nochmal zu verbilligen.
aktuell ist meine posi von 1500 ist groß genug... muss schon echt nochmal fett runter gehen um nochmal zu verbilligen.
Danke,
im Plus bin ich auch, aber es sind nur 500 Stück. Wenn das so weitergeht, befürchte ich mit einem Nachkauf nicht mehr hinterher zu kommen.
im Plus bin ich auch, aber es sind nur 500 Stück. Wenn das so weitergeht, befürchte ich mit einem Nachkauf nicht mehr hinterher zu kommen.
Antwort auf Beitrag Nr.: 66.507.965 von jossiff am 19.01.21 16:48:45die 10 wurde erklommen, nächste Ziel ist die 12... dann die 15
seit der 9€ bin ich wieder im plus, mein Call läuft auch sehr gut.
zum ende des letzten jahres wurde viel abgestoßen, jetzt kommen die anleger zurück... auch mit der hoffnung dass die geschäfte besser laufen, das die strafe nicht zu hoch wird, das neue medis demnächst kommen...
so erklärt sich mir das ganze.
seit der 9€ bin ich wieder im plus, mein Call läuft auch sehr gut.
zum ende des letzten jahres wurde viel abgestoßen, jetzt kommen die anleger zurück... auch mit der hoffnung dass die geschäfte besser laufen, das die strafe nicht zu hoch wird, das neue medis demnächst kommen...
so erklärt sich mir das ganze.
Durchsuchen
| Zeit | Titel |
|---|---|
| 24.07.23 |